Common Contracts
2 similar Supplemental Indenture contracts by Valeant Pharmaceuticals International, Inc.
TENTH SUPPLEMENTAL INDENTURESupplemental Indenture • November 1st, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
TENTH SUPPLEMENTAL INDENTURE, dated as of September 17, 2013 (the “Tenth Supplemental Indenture”), by and among Przedsiębiorstwo Farmaceutyczne Jelfa S.A. (“Jelfa”), Valeant Europe B.V. (“VEBV”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).
TENTH SUPPLEMENTAL INDENTURESupplemental Indenture • November 1st, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
TENTH SUPPLEMENTAL INDENTURE, dated as of September 17, 2013 (the “Tenth Supplemental Indenture”), by and among Przedsiębiorstwo Farmaceutyczne Jelfa S.A. (“Jelfa”), Valeant Europe B.V. (“VEBV”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).
